Abstract     Description     Claims     Drawing  

EP2801370A1   [0009] 
WO2006135436A   [0098] 
US6395713B   [0109] 
WO9402595A   [0109] 
US20010007666A   [0109] 
US2003077829A   [0109] 
WO0347518A   [0109] 
WO0346185A   [0109] 
US6447796B   [0109] 
US2002130430A   [0109] 
WO0053722A   [0109] 
US20030077829A   [0109] 
EP52322A   [0126] 
EP36676A   [0126] 
EP88046A   [0126] 
EP143949A   [0126] 

Oncogene   [0007] 
Cancer Res   [0007] 
Cell   [0025] 
NCBI NLM   [0048] 
J. Mol. Biol.   [0048] 
J. Mol. Biol   [0050] 
J. Theor. Biol.   [0050] 
Nucleic Acids Res   [0052] 
Oncogene   [0053]  [0053] 
Mol. Cell. Biol.   [0061] 
EMBO   [0063] 
Appl. Microbiol. Biotechnol.   [0089] 
Goldman's The Pharmacological Basis of Therapeutics   [0104] 
Goldman's The Pharmacological Basis of Therapeutics   [0104] 
Remington's Pharmaceutical Sciences   [0106] 
Tratado de Farmacia Galénica   [0107] 
Remington: The Science and Practice of Pharmacy   [0107] 
Science   [0108] 
Science   [0108] 
Trends Cell Bio.   [0109] 
Delivery Strategies for Antisense Oligonucleotide Therapeutics   [0109] 
Mol. Membr. Biol.   [0109] 
Handb. Exp. Pharmacol.   [0109] 
ACS Symp. Ser.   [0109] 
Int. J. Cancer   [0109] 
Tumour Biol.   [0109] 
Bioconjug. Chem.   [0109] 
Proc. Natl. Acad. Sci. USA   [0126] 
Proc. Natl. Acad. Sci. USA   [0126] 
Histological typing of lung and pleural tumours   [0149]